Member Info for drshan

Yeah guy's, thks for that. Micro this micro that, all lost on me skim reading. I'll have to start using the old control + F command to find keywords again, lol.

Well that does bode well for their colab, and perhaps Gerry can generate that much-needed income stream for them and welcome added value for us....if they have managed to mod and customise to work with MW kit so quickly, a feather in someone's cap. Symbiosis. If Microsaic's SP comes down to around 1.7ish I'll consider buying a chunk.

@oxygen
You said:
"Also good to see very early involvement of Microsaic’s products here which bodes well for their future."

Where did you read that, I can't seem to see it? That is very surprising if true and puts a new complection on the colab with Microsaic.

Yeah, great news. Funny this is so timely, my moaning about an RNS like Michigan needed to change sentiment and generate some traction, and here it is with knobs on!

Good stuff Gerard, one like this every month plz.

Bernard, I'm not a doctor, studied radiography and radiology at Leeds; drshan was supposed to be darshan - slip up on my part. Re Avacta's test I will reserve judgement upon full clinical validation, don't have the necessary science chops to proffer an opinion. I thought it looked excellent for what that's worth (nothing of course).

'' every person who tests positive will have to get a PCR test''.
Hasn't that stopped now as from end of January?

You mean on the back of having had a positive LFT test? Cannot see how that high sensitivity confirmation is going to be removed, you need to know definitively do you not - PCR or something similar.

Well perhaps like myself, he also has a position here BERNARD. I'm mean, honestly I it's a stretch, whodathunkit, that some people invest broadly, clearly not you, but hey-ho.

No Kaeren, you are quite right, but that won't stop them been childish and tribal....Yawn, geez.

It's not gang warfare is it, I'm invested in many pharma's. NCYT will be fine, lot's going on here and the PCR contract I think will be renewed substantially. Avacta have their own patent folio, an oncology program, affimer platform with tie up's and lots more besides; stop having a sneaky peek trying to compare, lol, NCYT has lots of irons in the fire of its own and any hand wringing will make not a jot of difference. Don't understand this pathetic tribalism because at the moment we are not in direct competition. If Bruker sort out BAMS to be rolled out worldwide, then possible minor worry but that seems a ways off so...Nil desperadum .

"If you have had the vaccine and you want to go to a football match/theatre/pop concert etc it will not be an antigen test it will be an antibody test that shows the vaccine has worked."

Antibody testing demonstrates a desired immune response that demonstrates vaccine efficacy, and also might be used to show/ determine antibody protection still present in months to come, no.

Antigen test, a good one, useful for highlighting infectiousness/high viral and potential to transmit to others. This is the test you want for: football match/theatre/pop concert etc

Yeah well, look back at the presentation slides re: production ramp-up, 90+% is antigen LFT not antibody LFT. RTC-19 test is an antibody LFT. Knickers in knots I think.

"Hi. Can any one help me understand how off of the back of very similar news and results. Avct share price jumps 30% and Odx 3%?"

Yes, its because Avacta can now license out their test to any manufacturer like ODX, globally, it also derisks their IP Affimers which have just been proven

Well think your getting ahead somewhat, A sample of 30 gives an encouraging readout, but let's wait for the validation proper before claim any of that.

And in addition to Badgers response, antibody testing, and its potential volume/necessity is a little up in the air at the moment.

Like most shares (clearly Tesla excepted) people, serious people want to see 'contracts' with 'detail' vis-à-vis hard numbers to calculate earnings and profits from. when we get that - stand back.

I'm with 100% Think some here are going doolally after the months of waiting for something definitive. They're chasing ghosts, seeing shadows where there are non....It's the same on AVACTA and NYCT to be fair.

Did we read the same RNS, I didn't see anything about payment upfront, in-kind, yes - upon some commercial outcome. It seems clear that their expertise and technology are being sought to add additional weight to the data already generated.

This is the crux Paul, Retire, David, rest of you, I was very buoyant, filled with expectation after results, perception, sentiment really matters, as does propriety, but these recent antics smack of the teen who cannot help but push the envelope and court trouble, and to our detriment (cost me many paper thousands already) it's hard to swallow; and yes the placee's effectively own 80+ pcent of MSYS.

I've just deleted a large piece of text b'cos, well it's not positive.

I'm hoping that the new skintrustclub really takes off, sending the share price soaring, I realise I've said this before. Just have to hope he stops f'kin around and gets his head down, gives us some large michigan type contracts, something RNSable. I am exasperated to say the least.

Oh and I agree, I think some of our fall is down to people who don't understand the magnitude of the dilution properly buying in over there. I certainly wouldn't.

https://twitter.com/gjbrandon/status/1361029178179600386

Yeah, Meh! I'm invested in NCYT, ODX, AVACTA and he is ignoring some rather large elephants stomping around the room. Contracts for gen2 antigen LFT are in the offing, AVACTA affimer test will almost certainly eclipse the poor LFT's largely utilised thus far. They're also working on a hybrid S+N for the mid to long term, BAMS may come through...NCYT have lots of potential to generate substantial future revenues no doubt (why I still have a large position here - for the £12+ potential) but this analysis ignores lots of other compelling development. IMHO.

Well I've unlocked a 20k chunk, if we see anything like 50odd it will be in as well.

One word - PRICELESS......ok that's 3 words, err LOL

Autocorrecting grammar, punctuation and spelling on the fly is painful, take pity on the literate, please. Cringe.